Date of event: estimated.The unique device identifier (udi) is unknown because the part and lot numbers were not provided.Date of implant: estimated.The devices were not returned for analysis as they remain implanted.A review of the lot history records and complaint histories could not be conducted because the lot and part numbers were not provided.The patient effects listed are consistent with the product risk profile and are therefore expected.A conclusive cause for the difficulties listed can not be determined based on the limited information available.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.Article title: impact of coronary calcification on outcomes after absorb scaffold implantation: insights from the gabi-r registry.
|
This is filed to report the serious injuries.It was reported through a research article identifying the absorb bioresorbable scaffolds that may be related to the following: cardiac death, target lesion revascularization, target vessel myocardial infarction, definite or probable scaffold thrombosis, major adverse cardiac events, hemorrhage, perforation, renal failure, stroke and percutaneous coronary intervention.This article summarizes clinical outcomes of 3140 patients with 3790 lesions, treated with the absorb bioresorbable vascular scaffold.Details are listed in the article titled, "impact of coronary calcification on outcomes after absorb scaffold implantation: insights from the gabi-r registry".
|